Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs

Autor: Rebello, S. S., Kasiewski, C. J., Bentley, R. G., Morgan, S. R., Chu, V., Bostwick, J. S., Klein, S. I., Perrone, M. H., Leadley, R. J.

Publikováno v: Thrombosis Research; 2001, Vol. 102 Issue: 3 p261-271, 11p

Design of a New Class of Orally Active Fibrinogen Receptor Antagonists

Autor: Klein, S. I., Molino, B. F., Czekaj, M., Gardner, C. J., Chu, V., Brown, K., Sabatino, R. D., Bostwick, J. S., Kasiewski, C., Bentley, R., Windisch, V., Perrone, M., Dunwiddie, C. T., Leadley, R. J.

Publikováno v: Journal of Medicinal Chemistry; July 2, 1998, Vol. 41 Issue: 14 p2492-2502, 11p

RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.

Autor: Fitzpatrick, L R, Lambert, R M, Pendley, C E, Martin, G E, Bostwick, J S, Gessner, G W, Airey, J E, Youssefyeh, R D, Pendleton, R G, Decktor, D L

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; August 1990, Vol. 254 Issue: 2 p450-455, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation factor Xa.

Autor: Leadley RJ Jr; Cardiovascular Drug Discovery, Rhône-Poulenc Rorer International, Collegeville, Pennsylvania 19426, USA. ROBERT.LEADLEY@RP-RORER.COM, Morgan SR, Bentley R, Bostwick JS, Kasiewski CJ, Heran C, Chu V, Brown K, Moxey P, Ewing WR, Pauls H, Spada AP, Perrone MH, Dunwiddie CT

Publikováno v: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 1999 Dec; Vol. 34 (6), pp. 791-9.